Alx Oncology Holdings (ALXO) Retained Earnings (2019 - 2026)
Alx Oncology Holdings (ALXO) reported Retained Earnings of -$740.7 million for Q1 2026, down 627849.15% on a YoY basis from N/an in Q1 2025, and down 2.48% sequentially from -$722.8 million in Q4 2025.
Alx Oncology Holdings (ALXO) Retained Earnings (2019 - 2026) Analysis & Trends
Alx Oncology Holdings (ALXO) has 8 years of Retained Earnings data on file, last reported at -$740.7 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 627849.15% year-over-year to -$740.7 million; the trailing twelve-month figure through Mar 2026 stood at -$740.7 million (down 627849.15% YoY), and the FY2025 full-year result was -$722.8 million, down 262942.55% from the prior year.
- Retained Earnings fell to -$740.7 million in Q1 2026, from -$722.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $275000.0 in Q4 2024 to a low of -$740.7 million in Q1 2026.
- A 5-year average of -$231.5 million and a median of -$1.5 million in 2022 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 321.43% in 2025, while the deepest fall reached 928427.4% in 2025.
- Tracing ALXO's Retained Earnings over 5 years: stood at -$325.5 million in 2022, then soared by 100.08% to $256000.0 in 2023, then rose by 7.42% to $275000.0 in 2024, then slumped by 262942.55% to -$722.8 million in 2025, then decreased by 2.48% to -$740.7 million in 2026.
- Business Quant data shows ALXO's Retained Earnings at -$740.7 million in Q1 2026, -$722.8 million in Q4 2025, and $43000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - | -740.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -740.74 Mn |
| Dec 31, 2025 | -722.82 Mn |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | -677.83 Mn |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 275,000.00 |
| Sep 30, 2024 | -591.96 Mn |
| Jun 30, 2024 | -73,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Sep 30, 2023 | -226,000.00 |
| Jun 30, 2023 | -389.81 Mn |
| Mar 31, 2023 | -88,000.00 |
| Dec 31, 2022 | -325.47 Mn |
| Sep 30, 2022 | -1.50 Mn |
| Jun 30, 2022 | -259.44 Mn |
| Mar 31, 2022 | -226.52 Mn |
| Dec 31, 2021 | -201.99 Mn |
| Sep 30, 2021 | -173.55 Mn |
| Jun 30, 2021 | -148.98 Mn |